News
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...
A new study reveals that the popular diabetes and weight-loss drug Ozempic might hold the key to relieving chronic migraines, ...
A WOMAN who has lost almost six stone in just nine months on Mounjaro has hit back at trolls calling it the “easy way out”.
For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...
Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
Hims & Hers Health delivered a first quarter that surpassed Wall Street’s expectations, driven by strong adoption of its ...
For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and MIDAS scores.
To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...
Muscle loss is common among those on GLP-1 receptor agonists — like semaglutide or liraglutide — which mimic gut hormones to ...
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results